Abstract: Epstein-Barr virus EBNA-LP protein is a transcriptional coactivator of EBNA2. Efficient nuclear localization of EBNA-LP is essential for cooperation with EBNA2. Here, we report the crystal structure of the nuclear import adaptor importin-a1 bound to the nuclear localization signal (NLS) of EBNA-LP that shows EBNA-LP residues 44-RRVRRR-49 binding to the major NLS-binding site at the P0-P5 positions. In contrast to previously characterized classical NLSs that invariably have a basic residue [either lysine (in the vast majority of cases) or arginine] at the P2 position, the EBNA-LP NLS is unique in that it has valine at the P2 position. The loss of the critical P2 lysine (or arginine) is compensated by arginine at the P0 position in the EBNA-LP NLS.
Introduction
Epstein-Barr virus (EBV) infection is associated with a diverse range of human tumors of both lymphoid and epithelial origin. 1 Epstein-Barr nuclear antigen 2 (EBNA2) and Epstein-Barr nuclear antigen leader protein (EBNA-LP) are EBV-encoded transcription factors that cooperatively up-regulate viral and cellular gene expression and thereby contribute to conversion of human B-lymphocyte to potentially malignant lymphoblastoid cell lines. [1] [2] [3] [4] [5] [6] [7] Efficient nuclear localization of EBNA-LP is essential for cooperation with EBNA2. 8 Transport of macromolecules between the cytoplasm and nucleus through nuclear pore complexes (NPCs) is a signal-mediated active process that depends on concerted interactions between soluble transport factors, cargo macromolecules, and nuclear pore proteins. 9 The importin (Imp) a:b-dependent classical nuclear import pathway is one of the major nuclear transport pathways. 9, 10 The armadillo (ARM) repeat domain of Impa bind cargo proteins by recognizing the classical nuclear localization signal (cNLS). Impa also binds Impb through the N-terminal Impb-binding (IBB) domain. The ternary Impa:b-cargo complexes can dock at and move through NPCs. Upon reaching the nucleoplasmic side of NPCs, the Impa:b-cargo complexes are dissociated by the small GTPase Ran. The majority of cNLSs recognized by Impa can be classified into two distinct classes: (i) the monopartite cNLS, containing a single stretch of basic amino acids as exemplified by the SV40 T antigen NLS (126-PKKKRKV-132), and (ii) the bipartite cNLS, comprising two stretches of basic amino acids separated by a linker of variable length. 11, 12 The monopartite cNLSs bind to the major NLS-binding site located on ARM repeats 2-4 of Impa. The bipartite cNLSs bind to this major site as well as the minor NLS-binding site located on ARM repeats 6-8 of Impa. 10, 12 EBNA-LP contains multiple copies of 22-and 44-amino acid segments encoded by W1 and W2 exons, followed by 11-and 34-amino acid segments encoded by Y1 and Y2 exons. 1 The 44-amino acid segment encoded by the W2 exon contains the EBNA-LP NLS that has two stretches of basic amino acids, RRHR and RRVRRR. 8 In an effort to characterize the interaction between EBNA-LP and nuclear import machinery, we have determined the crystal structure of the nuclear import adaptor Impa1 bound to the EBNA-LP NLS.
Results and Discussion
Structure of Impa1 bound to the EBNA-LP NLS peptide
We obtained crystals of the NLS-binding ARM repeat domain of Impa1 bound to the NLS peptide of EBNA-LP, and determined the structure at 2.15 Å resolution by molecular replacement (Table I ). The structure was refined to free and working R-factor values of 21.0% and 18.5%, respectively. Residues 43-50 of the NLS peptide bound to the major NLSbinding site of Impa1 were identified unambiguously in the electron density map [ Fig. 1(A) ].
At the major NLS-binding site, the EBNA-LP NLS adopted an extended conformation and bound along the concave surface of Impa1 on ARM repeats 2-4 [ Fig. 1(B) ]. EBNA-LP residues 44-49 occupied the P0-P5 positions and formed an extensive network of interactions with Impa1 [ Fig. 2 , and W142
Impa1
. The observation that EBNA-LP residues 43-50 had well defined electron density at the major NLS-binding site is consistent with the fact that these residues can function as a strong NLS, 8 and indicates that Impa:b can mediate nuclear import of EBNA-LP. Although it was previously reported that EBNA-LP residues 29-50 can function as a bit stronger NLS than EBNA-LP residues 43-50, 8 EBNA-LP residues 29-42 did not have well defined electron density and so probably did not interact stably with Impa1 in the crystal.
Implications for NLS sequence requirements
At present, more than 30 crystal structures of Impa:cNLS complexes are released in the Protein Data Bank (PDB). 12 In all of the published crystal structures of the Impa:cNLS complexes, the cNLSs bound to the major NLS-binding site invariably have lysine at the P2 position, which fit into the acidic P2 pocket [marked by a dashed circle in Fig.  2(C) ] in essentially the same way as observed for K128 of the monopartite SV40 T antigen cNLS at the P2 position. 15, 16 The published structures, together with mutational and thermodynamic analyses, 17, 18 have led to three suggestions: (i) the particular shape and chemistry of the P2 pocket constrains the binding to lysine, (ii) lysine is energetically favored at the P2 position, and (iii) mutation of the P2 lysine destroys the function as a nuclear localization signal. Although the cNLS of the crystal structure of Impa:BFDV cap NLS peptide complex (PDB code, 4HTV; Patterson et al., unpublished) shows that this NLS has arginine at the P2 position, the way this arginine binds to the P2 pocket is quite similar to the way K128 of SV40 cNLS binds to the P2 pocket. It was therefore a surprise to find that the EBNA-LP NLS has valine at the P2 position. Interestingly, in the case of the EBNA-LP NLS, the side chain of R44 at the P0 position extends into the P2 pocket [ Fig. 2(C) ] and makes one salt bridge and two hydrogen bonds with the Impa1 residues (G150, T155, and D192) that normally interact with the P2 lysine Ne. Thus, the loss of the critical P2 lysine (or arginine) residue is compensated by the P0 arginine in the EBNA-LP NLS. In summary, we have established the structure of the Impa1:EBNA-LP NLS complex, and the unusual way in which EBNA-LP binds to the critical P2 pocket in the major NLS-binding site indicates that the NLS sequence recognized by Impa is more diverse than previously thought.
Materials and Methods
Preparation of protein-peptide complex for crystallization N-terminally His 6 -and S-tagged DIBB Impa1 (mouse, residues 70-529; UniProt code, P52293) 16 was expressed from pET30a (Novagen) in the E. coli host strain BL21-CodonPlus(DE3)RIL (Stratagene), and was purified over Ni-NTA (Novagen) and gel filtration over Superdex200 (GE Healthcare). EBNA-LP (UniProt code, Q8AZK7) NLS peptide 29-RRHRSPSPTRGGQEPRRVRRRV-50 was synthesized by GenScript. Prior to crystallization, DIBB Impa1 and the NLS peptide were mixed in a molar ratio of 1:3 in 10 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 2 mM 2-mercaptoethanol.
Crystallization, data collection, and structure determination
Crystals of DIBB Impa1 bound to the EBNA-LP NLS peptide were grown at 208C from 0.2 mM DIBB Impa1 and 0.6 mM NLS peptide by hanging drop vapor diffusion against 0.1 M MES (pH 7.0), 0.75 M sodium citrate, and 10 mM DTT. Crystals were cryoprotected by addition of 23% glycerol, and flashcooled in liquid nitrogen. X-ray diffraction datasets were collected at 95 K at Photon Factory beamline BL-17A using a Pilatus3 S6M detector. Diffraction data were processed using MOSFLM and CCP4 programs. 19 The structure was solved by molecular replacement using MOLREP 20 using the structure of DIBB Impa1 bound to EBNA1 NLS peptide (PDB code, 5WUM) 21 as a search model. The structure was refined by iterative cycles of model building using COOT 22 and refinement using PHENIX. 23 MolProbity 13 was used to validate the final model. Structural figures were produced using CCP4MG 14 and PyMOL (DeLano Scientific).
Accession number
The coordinates and structure factors of mouse Impa1 bound to the EBNA-LP NLS peptide have been deposited in the PDB with accession code 5X8N.
